Drug Discovery & Delivery

From lab bench to pharmacy shelves, drug discovery takes up to fifteen years and costs $4B with an average failure rate of 80%. Half of this time and approximately 70% of all associated biopharmaceutical R&D costs are spent on in-vitro development alone.

Over a century ago, Paul Ehrlich described the ideal drug, famously known as a 'magic bullet,' in which it specifically targets the disease site and would not harm healthy tissue. Aptagen has developed the concept of a 'replicating magic bullet' called an aptamer. Aptamer technology has a shorter development time compared to traditional methods, and can be used to increase the specificity and improve delivery of existing drug compounds resulting in the next generation of pharmaceuticals with improved pharmacodynamics and pharmacokinetics.